LGALS9 and neoplasm: Rather than interacting with immune cells, it is found that the expression of Gal-9 on the surface of tumor cells reduces the invasiveness of breast cancer cells by limiting their capacity to invade the surrounding extracellular matrix (ECM) and attach to the vascular endothelium [55].